Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2686-2692

  Pavić, Ivica ^a   Hartmann, Anke ^a,b   Zimmermann, Albert ^a   Michel, Detlef ^a   Hampl, Walter ^a   Schleyer, Ingrid ^a   Mertens, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; VIRUS GLYCOPROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STRAIN DIFFERENCE; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0030784667     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2686     Document Type: Article

References (20)

1. Collins, P., and D. J. Bauer. 1977. Relative potencies of anti-herpes compounds. Ann. N. Y. Acad. Sci. 284:49-59.
2. Ellis, M. N., P. M. Keller, J. A. Fyfe, J. L. Martin, J. F. Rooney, S. E. Strauss, S. N. Lehrman, and D. W. Barry. 1987. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob. Agents Chemother. 31:1117-1125.
3. Erlich, K. S., J. Mills, P. Chatis, G. J. Mertz, D. F. Busch, S. E. Follansbee, R. M. Grant, and C. S. Crumpacker. 1989. Acyclovir-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 302:293-296.
4. Gadler, H. 1983. Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication. Antimicrob. Agents Chemother. 24:370-374.
5. Gadler, H., A. Larsson, and E. Solver. 1984. Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis. Antiviral Res. 4:63-70.
6. Jennings, S. R., P. A. Lippe, K. J. Pauza, P. G. Spear, L. Pereira, and S. S. Tevethia. 1987. Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J. Virol. 61:104-112.
7. Kruppenbacher, J. P., R. Kläss, and H. J. Eggers. 1994. A rapid and reliable assay for testing acyclovir sensitivity of clinical herpes simplex virus isolates independent of virus dose and reading time. Antiviral Res. 23:11-22.
8. Langlois, M., J. P. Allard, F. Nugier, and M. Aymard. 1986. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand. 14:201-211.
9. McLaren, C., M. N. Ellis, and G. A. Hunter. 1983. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 3:223-234.
10. McSharry, J. J. 1994. Uses of flow cytometry in virology. Clin. Microbiol. Rev. 7:576-604.
11. Michel, D., I. Pavić, A. Zimmermann, E. Haupt, K. Wunderlich, M. Heuschmid, and T. Mertens. 1996. The UL97 gene product of the human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:6340-6347.
12. Plummer, G., and M. Benyesh-Melnick. 1964. A plaque reduction neutralization test for human cytomegalovirus. Proc. Soc. Exp. Biol. Med. 117:145-150.
13. Prichard, M. N., S. R. Turk, L. A. Coleman, S. L. Engelhardt, C. Shipman, Jr., and J. C. Drach. 1990. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus. J. Virol. Methods 28:101-106.
14. Rabalais, G. P., M. J. Levin, and F. E. Berkowitz. 1987. Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Antimicrob. Agents Chemother. 31:946-948.
15. Rosenthal, K. S., C. M. Hodnichak, and J. L. Summers. 1987. Flow cytometric evaluation of anti-herpes drugs. Cytometry 8:392-395.
16. Safrin, S., T. Elbeik, L. Phan, D. Robinson, J. Rush, A. Elbaggari, and J. Mills. 1994. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38:1246-1250.
17. Shipman, C., Jr., S. H. Smith, R. H. Carlson, and J. C. Drach. 1976. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Antimicrob. Agents Chemother. 9:120-127.
18. Steele-Mortimer, O. A., H. Meier-Ewert, R. Loser, and M. J. Hasmann. 1990. Flow cytometric analysis of virus-infected cells and its potential use for screening antiviral agents. J. Virol. Methods 27:241-252.
19. Wahren, B., J. Harmenberg, V.-A. Sundqvist, B. Leven, and B. Sköldenberg. 1983. A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J. Virol. Methods 6:141-149.
20. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.